{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T04:11:38Z","timestamp":1747282298284,"version":"3.40.5"},"reference-count":36,"publisher":"Galenos Yayinevi","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["tjo"],"DOI":"10.4274\/tjo.galenos.2024.55313","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T13:56:19Z","timestamp":1742392579000},"source":"Crossref","is-referenced-by-count":0,"title":["Rational Drug Use in Extraocular Surgeries"],"prefix":"10.4274","author":[{"given":"Dudu Deniz","family":"A\u00e7ar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasemin","family":"Aslan Kat\u0131rc\u0131o\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2025,3,19]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.4103\/ijo.IJO_961_17","article-title":"Antibiotic prophylaxis in cataract surgery - an evidence-based approach","volume":"65","author":"Haripriya","year":"2017","unstructured":"1. Haripriya A. Antibiotic prophylaxis in cataract surgery - an evidence-based approach. Indian J Ophthalmol. 2017;65:1390-1395.","journal-title":"Indian J Ophthalmol"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1167\/iovs.15-16486","article-title":"Effects of gelatin hydrogel loading mitomycin C on conjunctival scarring in a canine filtration surgery model","volume":"56","author":"Kojima","year":"2015","unstructured":"2. Kojima S, Sugiyama T, Takai S, Jin D, Ueki M, Oku H, Tabata Y, Ikeda T. Effects of gelatin hydrogel loading mitomycin C on conjunctival scarring in a canine filtration surgery model. Invest Ophthalmol Vis Sci. 2015;56:2601-2605.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1136\/bjo.2008.153197","article-title":"Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study","volume":"94","author":"Galor","year":"2010","unstructured":"3. Galor A, Karp CL, Chhabra S, Barnes S, Alfonso EC. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study. Br J Ophthalmol. 2010;94:551-554.","journal-title":"Br J Ophthalmol"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"4. Dortzbach RK, Segrest DR. Orbital Aspergillosis. Ophthalmic Surg. 1983;14:240-244.","DOI":"10.3928\/1542-8877-19830301-05"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Dupr\u00e9 R, Baillif S, Lotte R, Ruimy R, Lagier J, Berrouane Y, Gawdat T, Fendri M, Martel A. Is topical antibiotic use necessary to prevent surgical site infection following oculoplastic surgery? Graefes Arch Clin Exp Ophthalmol. 2024;262:3331-3343.","DOI":"10.1007\/s00417-024-06489-8"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jaapos.2007.10.005","article-title":"Postoperative povidone-iodine prophylaxis in strabismus surgery","volume":"12","author":"Koederitz","year":"2008","unstructured":"6. Koederitz NM, Neely DE, Plager DA, Boehmer B, Ofner S, Sprunger DT, Sondhi N, Roberts G. Postoperative povidone-iodine prophylaxis in strabismus surgery. J AAPOS 2008;12:396-400.","journal-title":"J AAPOS"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/S0161-6420(91)32052-9","article-title":"Prophylaxis of endophthalmitis with topical povidone-iodine","volume":"98","author":"MG","year":"1991","unstructured":"7. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991;98:1769-1775.","journal-title":"Ophthalmology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1097\/IOP.0b013e3182916674","article-title":"Prophylactic postoperative antibiotics for enucleation and evisceration","volume":"29","author":"Fay","year":"2013","unstructured":"8. Fay A, Nallassamy N, Pemberton JD, Callahan A, Wladis EJ, Nguyen J, Durand ML. Prophylactic postoperative antibiotics for enucleation and evisceration. Ophthal Plast Reconstr Surg. 2013;29:281-285.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.bjoms.2012.08.008","article-title":"Part 1: orbital fractures in 62 patients","volume":"51","author":"Zix","year":"2013","unstructured":"9. Zix J, Schaller B, Iizuka T, Lieger O. The role of postoperative prophylactic antibiotics in the treatment of facial fractures: a randomised, double-blind, placebo-controlled pilot clinical study. Part 1: orbital fractures in 62 patients. Br J Oral Maxillofac Surg. 2013;51:332-336.","journal-title":"Br J Oral Maxillofac Surg"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1001\/archotol.1987.01860100033016","article-title":"Antibiotic prophylaxis for facial fractures: a prospective, randomized clinical trial","volume":"113","author":"RA","year":"1987","unstructured":"10. Chole RA, Yee J. Antibiotic prophylaxis for facial fractures: a prospective, randomized clinical trial. Arch Otolaryngol Head and Neck Surg. 1987;113:1055-1057.","journal-title":"Arch Otolaryngol Head and Neck Surg"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/lary.27210","article-title":"Postoperative prophylactic antibiotics for facial fractures: a systematic review and meta-analysis","volume":"129","author":"Habib","year":"2019","unstructured":"11. Habib AM, Wong AD, Schreiner GC, Satti KF, Riblet NB, Johnson HA, Ossoff JP. Postoperative prophylactic antibiotics for facial fractures: a systematic review and meta-analysis. Laryngoscope. 2019;129:82-95.","journal-title":"Laryngoscope"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.joms.2017.01.025","article-title":"Antibiotic prophylaxis in blepharoplasty: review of the current literature","volume":"75","author":"Ferneini","year":"2017","unstructured":"12. Ferneini EM, Halepas S, Aronin SI. Antibiotic prophylaxis in blepharoplasty: review of the current literature. J Oral Maxillofac Surg. 2017;75:1477-1481.","journal-title":"J Oral Maxillofac Surg"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1016\/S0161-6420(03)00447-0","article-title":"Infection after blepharoplasty with and without carbon dioxide laser resurfacing","volume":"110","author":"Carter","year":"2003","unstructured":"13. Carter SR, Stewart JM, Khan J, Archer KF, Holds JB, Seiff SR, Dailey RA. Infection after blepharoplasty with and without carbon dioxide laser resurfacing. Ophthalmology. 2003;110:1430-1432.","journal-title":"Ophthalmology"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.fsc.2016.03.011","article-title":"Antibiotic use in facial plastic surgery","volume":"24","author":"Gonzalez-Castro J","year":"2016","unstructured":"14. Gonzalez-Castro J, Lighthall JG. Antibiotic use in facial plastic surgery. Facial Plast Surg Clin North Am. 2016;24:347-356.","journal-title":"Facial Plast Surg Clin North Am"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Kadaba VR, Ahluwalia H. Postoperative systemic antibiotic usage in elective eyelid surgery: is it really necessary? Orbit. 2022;41:321-323.","DOI":"10.1080\/01676830.2021.1901294"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"382","DOI":"10.4103\/ijo.IJO_616_18","article-title":"Oral versus single intravenous bolus dose antibiotic prophylaxis against postoperative surgical site infection in external dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction - a randomized study","volume":"67","author":"Sheth","year":"2019","unstructured":"16. Sheth J, Rath S, Tripathy D. Oral versus single intravenous bolus dose antibiotic prophylaxis against postoperative surgical site infection in external dacryocystorhinostomy for primary acquired nasolacrimal duct obstruction - a randomized study. Indian J Ophthalmol. 2019;67:382-385.","journal-title":"Indian J Ophthalmol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1111\/aos.16735","article-title":"Retrospective study in 1020 cases on the rate of surgical site infections after lacrimal surgery without prophylactic systemic antibiotics","volume":"102","author":"de Keizer","year":"2024","unstructured":"17. de Keizer ROB, Suwandi JS, van Limpt JC, Kluis C, H\u00f6tte G, Nagtegaal AP, Paridaens D. Retrospective study in 1020 cases on the rate of surgical site infections after lacrimal surgery without prophylactic systemic antibiotics. Acta Ophthalmol. 2024;102:963-967.","journal-title":"Acta Ophthalmol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1080\/01676830.2023.2227705","article-title":"Antibiotic utilization in endoscopic dacryocystorhinostomy: a multi-institutional study and review of the literature","volume":"43","author":"Boal","year":"2024","unstructured":"18. Boal NS, Chiou CA, Sadlak N, Sarmiento VA, Lefebvre DR, Distefano AG. Antibiotic utilization in endoscopic dacryocystorhinostomy: a multi-institutional study and review of the literature. Orbit. 2024;43:183-189.","journal-title":"Orbit"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ajo.2017.07.004","article-title":"Conjunctival autograft versus amniotic membrane transplantation for treatment of pterygium: findings from a cochrane systematic review","volume":"182","author":"Clearfield","year":"2017","unstructured":"19. Clearfield E, Hawkins BS, Kuo IC. Conjunctival autograft versus amniotic membrane transplantation for treatment of pterygium: findings from a cochrane systematic review. Am J Ophthalmol. 2017;182:8-17.","journal-title":"Am J Ophthalmol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"981663","DOI":"10.3389\/fmed.2022.981663","article-title":"Amniotic membrane transplantation and conjunctival autograft combined with mitomycin C for the management of primary pterygium: a systematic review and meta-analysis","volume":"9","author":"Taher","year":"2022","unstructured":"20. Taher NO, Alnabihi AN, Hersi RM, Alrajhi RK, Alzahrani RA, Batais WT, Mofti AH, Alghamdi SA. Amniotic membrane transplantation and conjunctival autograft combined with mitomycin C for the management of primary pterygium: a systematic review and meta-analysis. Front Med. 2022;9:981663.","journal-title":"Front Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/25158414211020152","article-title":"Pterygium: an update on pathophysiology, clinical features, and management","volume":"13","author":"Shahraki","year":"2021","unstructured":"21. Shahraki T, Arabi A, Feizi S. Pterygium: an update on pathophysiology, clinical features, and management. Ther Adv Ophthalmol. 2021;13:1-21.","journal-title":"Ther Adv Ophthalmol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/01676830600972724","article-title":"Comparison of three methods for the treatment of pterygium: amniotic membrane graft, conjunctival autograft and conjunctival autograft plus mitomycin C","volume":"26","author":"Katircio\u011flu","year":"2007","unstructured":"22. Katircio\u011flu YA, Altiparmak UE, Duman S. Comparison of three methods for the treatment of pterygium: amniotic membrane graft, conjunctival autograft and conjunctival autograft plus mitomycin C. Orbit. 2007;26:5-13.","journal-title":"Orbit"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.survophthal.2003.10.008","article-title":"Tumors of the conjunctiva and cornea","volume":"49","author":"CL","year":"2004","unstructured":"23. Shields CL, Shields JA. Tumors of the conjunctiva and cornea. Surv Ophthalmol. 2004;49:3-24.","journal-title":"Surv Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1586\/17469899.2014.921119","article-title":"Management of conjunctival malignant melanoma: a review and update","volume":"9","author":"Wong","year":"2014","unstructured":"24. Wong JR, Nanji AA, Galor A, Karp CL. Management of conjunctival malignant melanoma: a review and update. Expert Rev Ophthalmol. 2014;9:185-204.","journal-title":"Expert Rev Ophthalmol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000522195","article-title":"Adjunctive treatment with interferon alpha 2B in conjunctival melanoma","volume":"8","author":"Huerva","year":"2022","unstructured":"25. Huerva V, Cid-Bertomeu P, Espinet R, Canto LM. Adjunctive treatment with interferon alpha 2B in conjunctival melanoma. Ocul Oncol Pathol. 2022;8:88-92.","journal-title":"Ocul Oncol Pathol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.oftal.2015.12.012","article-title":"treatment with surgery following topical interferon alpha-2b","volume":"91","author":"Murcia Bello","year":"2016","unstructured":"26. Murcia Bello C, Lle\u00f3 P\u00e9rez AV, Navarro Piera JF. Giant conjunctival squamous cell carcinoma. treatment with surgery following topical interferon alpha-2b. Arch Soc Esp Oftalmol. 2016;91:188-190.","journal-title":"Arch Soc Esp Oftalmol"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s10792-008-9257-8","article-title":"Nigeria: a clinicopathological study of 46 cases","volume":"29","author":"Ogun","year":"2009","unstructured":"27. Ogun GO, Ogun OA, Bekibele CO, Akang EE. Intraepithelial and invasive squamous neoplasms of the conjunctiva in Ibadan. Nigeria: a clinicopathological study of 46 cases. Int Ophthalmol. 2009;29:401-409.","journal-title":"Int Ophthalmol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1542-0124(12)70129-5","article-title":"Current treatment options for conjunctival and corneal intraepithelial neoplasia","volume":"1","author":"JA","year":"2003","unstructured":"28. Giaconi JA, Karp CL. Current treatment options for conjunctival and corneal intraepithelial neoplasia. Ocul Surf. 2003;1:66-73.","journal-title":"Ocul Surf"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.ophtha.2011.11.035","article-title":"Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction","volume":"119","author":"Kim","year":"2012","unstructured":"29. Kim J, Shields C, Shah S, Kaliki S, Lally S. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction. Ophthalmol. 2012;119:938-944.","journal-title":"Ophthalmol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/ICO.0b013e318190937d","article-title":"Therapeutic effect of topical 5-fluorouracil in conjunctival squamous carcinoma is associated with changes in matrix metalloproteinases and tissue inhibitor of metalloproteinases expression","volume":"28","author":"Iovieno","year":"2009","unstructured":"30. Iovieno A, Lambiase A, Moretti C, Perrella E, Bonini S. Therapeutic effect of topical 5-fluorouracil in conjunctival squamous carcinoma is associated with changes in matrix metalloproteinases and tissue inhibitor of metalloproteinases expression. Cornea. 2009;28:821-824.","journal-title":"Cornea"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2147\/OPTH.S9709","article-title":"5-fluorouracil for the treatment of intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva, and cornea","volume":"4","author":"Al-Barrag","year":"2010","unstructured":"31. Al-Barrag A, Al-Shaer M, Al-Matary N, Al-Hamdani M. 5-fluorouracil for the treatment of intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva, and cornea. Clin Ophthalmol. 2010;4:801-808.","journal-title":"Clin Ophthalmol"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Giacconi JA, Karp CL. Current treatment options for conjunctival and corneal intraepithelial neoplasia. Ocular Surf. 2003;2:66-73.","DOI":"10.1016\/S1542-0124(12)70129-5"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1007\/s00417-013-2478-1","article-title":"Serial sub-conjunctival 5-fluorouracil for early recurrent anophthalmic contracted socket","volume":"251","author":"Kamal","year":"2013","unstructured":"33. Kamal S, Kumar S, Goel R, Bodh SA. Serial sub-conjunctival 5-fluorouracil for early recurrent anophthalmic contracted socket. Graefes Arch Clin Exp Ophthalmol. 2013;251:2797-2802.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1016\/j.ophtha.2011.01.059","article-title":"Invasive aspergillosis of orbit in immunocompetent patients: treatment and outcome","volume":"118","author":"Pushker","year":"2011","unstructured":"34. Pushker N, Meel R, Kashyap S, Bajaj MS, Sen S. Invasive aspergillosis of orbit in immunocompetent patients: treatment and outcome. Ophthalmology. 2011;118:1886-1891.","journal-title":"Ophthalmology"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1097\/01.iop.0000225418.50441.ee","article-title":"Indications for orbital exenteration in mucormycosis","volume":"22","author":"Hargrove","year":"2006","unstructured":"35. Hargrove RN, Wesley RE, Klippenstein KA, Fleming JC, Haik BG. Indications for orbital exenteration in mucormycosis. Ophthal Plast Reconstr Surg. 2006;22:286-291.","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1097\/00002341-199901000-00007","article-title":"Role of local amphotericin B therapy for sino-orbital fungal infections","volume":"15","author":"Seiff","year":"1999","unstructured":"36. Seiff SR, Choo PH, Carter SR. Role of local amphotericin B therapy for sino-orbital fungal infections. Ophthalmic Plast Reconstr Surg. 1999;15:28-31.","journal-title":"Ophthalmic Plast Reconstr Surg"}],"container-title":["Turkish Journal of Ophthalmology"],"original-title":[],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T14:06:50Z","timestamp":1747231610000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oftalmoloji.org\/articles\/rational-drug-use-in-extraocular-surgeries\/doi\/tjo.galenos.2024.55313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,19]]},"references-count":36,"URL":"https:\/\/doi.org\/10.4274\/tjo.galenos.2024.55313","relation":{},"ISSN":["1300-0659","2147-2661"],"issn-type":[{"type":"print","value":"1300-0659"},{"type":"electronic","value":"2147-2661"}],"subject":[],"published":{"date-parts":[[2025,3,19]]}}}